BRAF V600E

Clinical trials for BRAF V600E explained in plain language.

Never miss a new study

Get alerted when new BRAF V600E trials appear

Sign up with your email to follow new studies for BRAF V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Targeted attack on tough colon cancer before surgery

Disease control Completed

This study tested a combination of three targeted drugs (encorafenib, binimetinib, and cetuximab) given for 8 weeks before surgery to people with a specific genetic type of localized colon cancer (BRAF V600E mutated). The goal was to see if this 'neoadjuvant' approach could shrin…

Matched conditions: BRAF V600E

Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

BRAF V600E

Get alerted when new BRAF V600E trials appear

Targeted attack on tough colon cancer before surgery